Catheter Precision VTAK
NYSE VTAK
$0.17 -0.02 (-10.83%)
As of: Sep 9, 2026 · 3:59 PM EDT

Catheter Precision (VTAK) Net Cash Flow Growth (1y) (2018 - 2026)

Analysis

Catheter Precision (VTAK) Net Cash Flow Growth (1y) (2018 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF Growth (1y) (Qtr)
1 Abbott Laboratories 187.42 Bn 182.47 Bn 7.27 Bn -562.77%
2 Intuitive Surgical 129.78 Bn 124.69 Bn 1.96 Bn -9.88%
3 Medtronic 120.53 Bn 112.33 Bn 6.34 Bn 83.30%
4 Stryker 116.28 Bn 112.80 Bn 4.50 Bn 2,827.78%
5 Boston Scientific 69.29 Bn 68.99 Bn 3.85 Bn -395.56%
6 Edwards Lifesciences 51.83 Bn 47.68 Bn 1.35 Bn 168.38%
7 Alcon 34.36 Bn 32.91 Bn 1.68 Bn -593.75%
8 Dexcom 33.17 Bn 31.23 Bn 830.00 Mn -103.49%
9 Steris 21.90 Bn 21.43 Bn 684.20 Mn -54.17%
10 Catheter Precision 553,488.01 -1.71 Mn 98,000.00 -57.99%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -57.99%
Mar 31, 2026 114.40%
Dec 31, 2025 -160.75%
Sep 30, 2025 -82.35%
Jun 30, 2025 126.31%
Mar 31, 2025 -16.83%
Dec 31, 2024 179.69%
Sep 30, 2024 168.38%
Jun 30, 2024 69.32%
Mar 31, 2024 43.04%
Dec 31, 2023 -191.46%
Sep 30, 2023 -172.40%
Jun 30, 2023 26.30%
Mar 31, 2023 -239.66%
Dec 31, 2022 139.53%
Sep 30, 2022 538.64%
Jun 30, 2022 -252.93%
Mar 31, 2022 132.78%
Dec 31, 2021 42.80%
Sep 30, 2021 -90.72%